TY  - JOUR 
AU  - Sánchez Cánovas, M.
AU  - Fernández Garay, D.
AU  - Adoamnei, E.
AU  - Guirao García, E.
AU  - López Robles, J.
AU  - Cacho Lavin, D.
AU  - Martínez de Castro, E.
AU  - Campos Balea, Begoña
AU  - Garrido Fernandez, Alberto
AU  - Fernández Pérez, Isaura
AU  - Ferrández Arias, A.
AU  - Suarez, N.
AU  - Quintanar Verduguez, T.
AU  - Lobo de Mena, M.
AU  - Rodríguez, L.
AU  - Gutierrez, D.
AU  - Martín Fernández de Soiginie, A.M.
AU  - García Adrián, S.
AU  - Ferrer Pérez, A.I.
AU  - Delgado Heredia, M.J.
AU  - Muñoz Lerma, A.
AU  - Luque, R.
AU  - Mazariegos Rubí, M.
AU  - Rúperez Blanco, A.B.
AU  - García Escobar, I.
AU  - Mendiola, J.
AU  - Muñoz Martín, A.J.
PY  - 2023
SN  - 1699-3055
UR  - http://hdl.handle.net/20.500.11940/21593
AB  - Purpose: Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. Methods/patients: Retrospective,...
LA  - eng
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Venous Thromboembolism
KW  - Retrospective Studies
KW  - Urinary Bladder
KW  - Thrombosis
KW  - Medical Oncology
KW  - Carcinoma, Renal Cell
KW  - Kidney Neoplasms
KW  - Urinary Bladder Neoplasms
KW  - Serum Albumin
KW  - Risk Factors
TI  - Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
DO  - 10.1007/s12094-023-03171-z
T2  - Clinical and Translational Oncology
M2  - 3021
KW  - AS Lugo
KW  - CHULA
KW  - AS Vigo
KW  - CHUVI
KW  - AS Vigo
KW  - CHUVI
VL  - 25
ER  -